Tiffany Ho

Tiffany Ho is an accomplished research professional with extensive experience in biotechnology and therapeutic development. Currently serving as a Principal Research Associate at BlueRock Therapeutics since March 2022, Tiffany has progressed through various roles in reputable organizations including Cytiva and GE Healthcare, where positions included Senior Development Associate and Development Associate. Prior experience includes significant research contributions at the University Health Network and Mount Sinai Hospital, focusing on Oncolytic Virotherapy and Bone Biology, respectively. Tiffany holds a Master of Science in Oncolytic Virotherapy from the University of Toronto and a Bachelor of Science in Biotechnology/Economics from the University of Waterloo.